trial · primary record
Vedolizumab IV
Crohn's Disease
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 408 |
| Primary completion | 2031-05-30 |
| Primary endpoint | Percentage of Participants Achieving Clinical Response at Week 14 |
| Registry ID | NCT05837897 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:44.145Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05837897
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.